{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T07:27:13Z","timestamp":1749022033320},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00520-017-3706-8","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T11:43:26Z","timestamp":1492688606000},"page":"2871-2879","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis"],"prefix":"10.1007","volume":"25","author":[{"given":"A. R. T.","family":"Bergin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hovey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Parente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Rapke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"3706_CR1","doi-asserted-by":"publisher","unstructured":"Hovey E, Souza P de, Marx G, et al (2014) Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Support Care Cancer 22:1233\u20131242. doi: 10.1007\/s00520-013-2076-0","DOI":"10.1007\/s00520-013-2076-0"},{"key":"3706_CR2","first-page":"13","volume":"34","author":"D Cella","year":"1997","unstructured":"Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34:13\u201319","journal-title":"Semin Hematol"},{"key":"3706_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/cncr.20423","volume":"101","author":"M Hofman","year":"2004","unstructured":"Hofman M, Morrow GR, Roscoe JA et al (2004) Cancer patients\u2019 expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices. Cancer 101:851\u2013857. doi: 10.1002\/cncr.20423","journal-title":"Cancer"},{"key":"3706_CR4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","volume":"13","author":"AM Berger","year":"2015","unstructured":"Berger AM, Mooney K, Alvarez-Perez A et al (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw 13:1012\u20131039","journal-title":"J Natl Compr Cancer Netw"},{"key":"3706_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejca.2012.07.011","volume":"49","author":"MJ Heins","year":"2013","unstructured":"Heins MJ, Korevaar JC, Rijken PM, Schellevis FG (2013) For which health problems do cancer survivors visit their General Practitioner? Eur J Cancer 49:211\u2013218. doi: 10.1016\/j.ejca.2012.07.011","journal-title":"Eur J Cancer"},{"key":"3706_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0885-3924(99)00082-2","volume":"18","author":"PB Jacobsen","year":"1999","unstructured":"Jacobsen PB, Hann DM, Azzarello LM et al (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manag 18:233\u2013242","journal-title":"J Pain Symptom Manag"},{"key":"3706_CR7","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/PHM.0b013e31802ba53c","volume":"86","author":"WJ Evans","year":"2007","unstructured":"Evans WJ, Lambert CP (2007) Physiological basis of fatigue. Am J Phys Med Rehabil 86:S29\u2013S46","journal-title":"Am J Phys Med Rehabil"},{"key":"3706_CR8","doi-asserted-by":"crossref","unstructured":"(2002) Chronic fatigue syndrome. Clinical practice guidelines--2002. Med J Aust 176 Suppl:S23\u201356","DOI":"10.5694\/j.1326-5377.2002.tb04499.x"},{"key":"3706_CR9","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","volume":"89","author":"CS Cleeland","year":"2000","unstructured":"Cleeland CS, Mendoza TR, Wang XS et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89:1634\u20131646. doi: 10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","journal-title":"Cancer"},{"key":"3706_CR10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s001270050266","volume":"35","author":"D Hadzi-Pavlovic","year":"2000","unstructured":"Hadzi-Pavlovic D, Hickie IB, Wilson AJ et al (2000) Screening for prolonged fatigue syndromes: validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol 35:471\u2013479","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"3706_CR11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/PSY.0000000000000061","volume":"76","author":"BK Bennett","year":"2014","unstructured":"Bennett BK, Goldstein D, Chen M et al (2014) Characterization of fatigue states in medicine and psychiatry by structured interview. Psychosom Med 76:379\u2013388","journal-title":"Psychosom Med"},{"issue":"Suppl 1","key":"3706_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1634\/theoncologist.12-S1-35","volume":"12","author":"JA Roscoe","year":"2007","unstructured":"Roscoe JA, Kaufman ME, Matteson-Rusby SE et al (2007) Cancer-related fatigue and sleep disorders. Oncologist 12(Suppl 1):35\u201342. doi: 10.1634\/theoncologist.12-S1-35","journal-title":"Oncologist"},{"key":"3706_CR13","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa041318","volume":"351","author":"DP Petrylak","year":"2004","unstructured":"Petrylak DP, Tangen CM, Hussain MH et al (2004) Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351:1513\u20131520. doi: 10.1056\/NEJMoa041318","journal-title":"N Engl J Med"},{"key":"3706_CR14","doi-asserted-by":"publisher","unstructured":"Tannock IF, Wit R de, Berry WR, et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502\u20131512. doi: 10.1056\/NEJMoa040720","DOI":"10.1056\/NEJMoa040720"},{"key":"3706_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(15)01037-5","volume":"387","author":"ND James","year":"2016","unstructured":"James ND, Sydes MR, Clarke NW et al (2016) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet 387:1163\u20131177. doi: 10.1016\/S0140-6736(15)01037-5","journal-title":"Lancet"},{"key":"3706_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa1503747","volume":"373","author":"CJ Sweeney","year":"2015","unstructured":"Sweeney CJ, Chen Y-HH, Carducci M et al (2015) Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med 373:737\u2013746. doi: 10.1056\/NEJMoa1503747","journal-title":"N Engl J Med"},{"key":"3706_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/annonc\/mdv129","volume":"26","author":"S-EE Al-Batran","year":"2015","unstructured":"Al-Batran S-EE, Hozaeel W, Tauchert FK et al (2015) The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax). Ann Oncol 26:1244\u20131248. doi: 10.1093\/annonc\/mdv129","journal-title":"Ann Oncol"},{"key":"3706_CR18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1158\/1078-0432.CCR-06-2046","volume":"13","author":"R Dreicer","year":"2007","unstructured":"Dreicer R, Petrylak D, Agus D et al (2007) Phase I\/II study of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer. Clin Cancer Res 13:1208\u20131215. doi: 10.1158\/1078-0432.CCR-06-2046","journal-title":"Clin Cancer Res"},{"key":"3706_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ejca.2011.12.026","volume":"48","author":"A Awada","year":"2012","unstructured":"Awada A, Hendlisz A, Christensen O et al (2012) Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours. Eur J Cancer 48:465\u2013474. doi: 10.1016\/j.ejca.2011.12.026","journal-title":"Eur J Cancer"},{"key":"3706_CR20","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1200\/JCO.2011.34.6148","volume":"30","author":"D Goldstein","year":"2012","unstructured":"Goldstein D, Bennett BK, Webber K et al (2012) Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. J Clin Oncol 30:1805\u20131812. doi: 10.1200\/JCO.2011.34.6148","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"3706_CR21","first-page":"S10","volume":"175","author":"IB Hickie","year":"2001","unstructured":"Hickie IB, Davenport TA, Hadzi-Pavlovic D et al (2001) Development of a simple screening tool for common mental disorders in general practice. Med J Aust 175(Suppl):S10\u2013S17","journal-title":"Med J Aust"},{"key":"3706_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM et al (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160\u2013164. doi: 10.1136\/bmj.305.6846.160","journal-title":"BMJ"},{"key":"3706_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-5-54","volume":"5","author":"S Farivar","year":"2007","unstructured":"Farivar S, Cunningham W, Hays R (2007) Correlated physical and mental health summary scores for the SF-36 and SF-12 health survey, V.1. Health Qual Life Out 5:1\u20138. doi: 10.1186\/1477-7525-5-54","journal-title":"Health Qual Life Out"},{"key":"3706_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1532-5415.2008.02091.x","volume":"57","author":"M Ketchandji","year":"2009","unstructured":"Ketchandji M, Kuo Y-FF, Shahinian VB, Goodwin JS (2009) Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc 57:24\u201330. doi: 10.1111\/j.1532-5415.2008.02091.x","journal-title":"J Am Geriatr Soc"},{"key":"3706_CR25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF01845757","volume":"4","author":"A Glaus","year":"1996","unstructured":"Glaus A, Crow R, Hammond S (1996) A qualitative study to explore the concept of fatigue\/tiredness in cancer patients and in healthy individuals. Support Care Cancer 4:82\u201396","journal-title":"Support Care Cancer"},{"key":"3706_CR26","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1200\/JCO.2005.07.024","volume":"23","author":"MA Andrykowski","year":"2005","unstructured":"Andrykowski MA, Schmidt JE, Salsman JM et al (2005) Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23:6613\u20136622. doi: 10.1200\/JCO.2005.07.024","journal-title":"J Clin Oncol"},{"key":"3706_CR27","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1200\/JCO.2001.19.14.3385","volume":"19","author":"D Cella","year":"2001","unstructured":"Cella D, Davis K, Breitbart W, Curt G (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385\u20133391","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"3706_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1634\/theoncologist.12-S1-22","volume":"12","author":"JL Ryan","year":"2007","unstructured":"Ryan JL, Carroll JK, Ryan EP et al (2007) Mechanisms of cancer-related fatigue. Oncologist 12(Suppl 1):22\u201334. doi: 10.1634\/theoncologist.12-S1-22","journal-title":"Oncologist"},{"key":"3706_CR29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/j.1532-5415.2010.02811.x","volume":"58","author":"NB Alexander","year":"2010","unstructured":"Alexander NB, Taffet GE, Horne FM et al (2010) Bedside-to-bench conference: research agenda for idiopathic fatigue and aging. J Am Geriatr Soc 58:967\u2013975. doi: 10.1111\/j.1532-5415.2010.02811.x","journal-title":"J Am Geriatr Soc"},{"key":"3706_CR30","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1200\/JCO.2014.55.3065","volume":"32","author":"A Naeim","year":"2014","unstructured":"Naeim A, Aapro M, Subbarao R, Balducci L (2014) Supportive care considerations for older adults with cancer. J Clin Oncol 32:2627\u20132634. doi: 10.1200\/JCO.2014.55.3065","journal-title":"J Clin Oncol"},{"key":"3706_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clgc.2013.07.003","volume":"12","author":"D Jones","year":"2014","unstructured":"Jones D, Zhao F, Fisch MJ et al (2014) The validity and utility of the MD Anderson symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer 12:41\u201349. doi: 10.1016\/j.clgc.2013.07.003","journal-title":"Clin Genitourin Cancer"},{"key":"3706_CR32","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1200\/JCO.2013.54.4346","volume":"32","author":"A Spathis","year":"2014","unstructured":"Spathis A, Fife K, Blackhall F et al (2014) Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol 32:1882\u20131888. doi: 10.1200\/JCO.2013.54.4346","journal-title":"J Clin Oncol"},{"key":"3706_CR33","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","volume":"31","author":"S Yennurajalingam","year":"2013","unstructured":"Yennurajalingam S, Frisbee-Hume S, Palmer JL et al (2013) Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31:3076\u20133082. doi: 10.1200\/JCO.2012.44.4661","journal-title":"J Clin Oncol"},{"key":"3706_CR34","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1200\/JCO.2012.45.3696","volume":"31","author":"E Bruera","year":"2013","unstructured":"Bruera E, Yennurajalingam S, Palmer JL et al (2013) Methylphenidate and\/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol 31:2421\u20132427. doi: 10.1200\/JCO.2012.45.3696","journal-title":"J Clin Oncol"},{"key":"3706_CR35","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/jnci\/djt181","volume":"105","author":"DL Barton","year":"2013","unstructured":"Barton DL, Liu H, Dakhil SR et al (2013) Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 105:1230\u20131238. doi: 10.1093\/jnci\/djt181","journal-title":"J Natl Cancer Inst"},{"key":"3706_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006145.pub3","volume":"11","author":"F Cramp","year":"2012","unstructured":"Cramp F, Byron-Daniel J (2012) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 11:CD006145. doi: 10.1002\/14651858.CD006145.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3706_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/annonc\/mdp479","volume":"21","author":"B Oh","year":"2010","unstructured":"Oh B, Butow P, Mullan B et al (2010) Impact of medical qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol 21:608\u2013614. doi: 10.1093\/annonc\/mdp479","journal-title":"Ann Oncol"},{"key":"3706_CR38","doi-asserted-by":"publisher","unstructured":"Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G (2009) Psychosocial interventions for reducing fatigue during cancer treatment in adults Cochrane Database Syst Rev:CD006953. doi: 10.1002\/14651858.CD006953.pub2","DOI":"10.1002\/14651858.CD006953.pub2"},{"key":"3706_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1040-8428(02)00176-2","volume":"47","author":"D Respini","year":"2003","unstructured":"Respini D, Jacobsen PB, Thors C et al (2003) The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47:273\u2013279. doi: 10.1016\/S1040-8428(02)00176-2","journal-title":"Crit Rev Oncol Hematol"},{"key":"3706_CR40","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jpain.2012.07.012","volume":"13","author":"DM Novy","year":"2012","unstructured":"Novy DM, Lam C, Gritz ER et al (2012) Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse. J Pain 13:1058\u20131067. doi: 10.1016\/j.jpain.2012.07.012","journal-title":"J Pain"},{"key":"3706_CR41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1200\/JCO.2000.18.4.743","volume":"18","author":"JE Bower","year":"2000","unstructured":"Bower JE, Ganz PA, Desmond KA et al (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743\u2013753","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3706-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3706-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3706-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T06:17:57Z","timestamp":1692771477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3706-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3706"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3706-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]}}}